Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA military informed consent rule back to drawing board

Executive Summary

FDA withdraws its final rule on determining the circumstances under which informed consent can be waived for troops being given investigational drugs in combat situations. The rule would finalize a 1999 1interim final rule, which specifies that the President, and not the FDA commissioner, can make the determination (2"The Pink Sheet" Nov. 29, 1999, p. 10). FDA pulled the rule Oct. 10 after submitting it to OMB July 21...

You may also be interested in...

DoD Investigational Drug Testing Policy Expected By Early Next Year

The Department of Defense will develop a protocol on the use of investigational drugs on military personnel that will incorporate the President's executive order and FDA's interim rule on seeking informed consent waivers. The protocol is expected by early next year.

Asia Deal Watch: Takeda, KSQ Take CRISPR Approach To T-Cell Oncology Therapy

Plus deals involving Astellas/Actinium, Sosei/PharmEnable, Aadi/EOC Pharma, BeiGene/Strand, Chi-Med/Inmagene, Alteogen/Intas, Sosei/AbbVie, Y-Biologics/3D Medicines.

J&J Has A Plan B If Gamechanger Single Dose Vaccine Disappoints

If J&J’s gamble on a single dose pays off, it could rapidly advance the fight against SARS-CoV2 – but a second study will provide a safety net.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts